![](https://daytontherapeutics.com/wp-content/uploads/2022/09/MarketWatch.png)
Dayton Therapeutics has announced that the company is using its AI-powered genetic and molecular research model for investigating new therapeutic uses of clinical stage drug candidates where development has been discontinued – in particular satraplatin. Satraplatin is…